Cargando…

Red Blood Cells are Appropriate Carrier for Coagulation Factor VIII

AIMS: Factor VIII (FVIII) replacement therapy remains a primary treatment for hemophilia A, however, the development of FVIII antibodies (inhibitors) and short half-life of the FVIII products are the major complications. Erythrocytes may prevent rapid removal of drugs from plasma. Erythrocytes are b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayyadipour, Fatemeh, Amirizadeh, Naser, Oodi, Arezoo, Khalili, Masoud, Saba, Fakhredin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360916/ https://www.ncbi.nlm.nih.gov/pubmed/31533604 http://dx.doi.org/10.2174/1871529X19666190918141859

Ejemplares similares

RHD Genotyping of Rh-Negative and Weak D Phenotype among Blood Donors in Southeast Iran
por: Sadeghi-Bojd, Younes, et al.
Publicado: (2021)

RHD Genotyping by Molecular Analysis of Hybrid Rhesus box in RhD-Negative Blood Donors from Iran
por: Khosroshahi, Behzad Nazel, et al.
Publicado: (2018)

Long noncoding RNAs (lncRNAs) in human lymphomas
por: Gholami, Ali, et al.
Publicado: (2021)

The Rh blood group system and its role in alloimmunization rate among sickle cell disease and sickle thalassemia patients in Iran
por: Jalali Far, Mohammad Ali, et al.
Publicado: (2021)

Mesenchymal Stem Cells as a Feeder Layer Can Prevent Apoptosis of Expanded Hematopoietic Stem Cells Derived from Cord Blood
por: Mehrasa, Roya, et al.
Publicado: (2014)

Elevated expression of DNMT1 is associated with increased expansion and proliferation of hematopoietic stem cells co-cultured with human MSCs
por: Ahmadnejad, Moharram, et al.
Publicado: (2017)

Blood group genotyping in alloimmunized multi‐transfused thalassemia patients from Iran
por: Sarihi, Reyhaneh, et al.
Publicado: (2021)

Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes
por: Dalm, Daniela, et al.
Publicado: (2015)

FACTOR VIII COAGULANT ACTIVITY AND FACTOR VIII-LIKE ANTIGEN: INDEPENDENT MOLECULAR ENTITIES
por: Zimmerman, Theodore S., et al.
Publicado: (1973)

Development and Characterization of Recombinant Ovine Coagulation Factor VIII
por: Zakas, Philip M., et al.
Publicado: (2012)

Bacterial Production of Recombinant Coagulation Factor VIII Domains
por: Bashar, Saima, et al.
Publicado: (2023)

Limited Promiscuity of HLA-DRB1 Presented Peptides Derived of Blood Coagulation Factor VIII
por: van Haren, Simon D., et al.
Publicado: (2013)

Characterization and visualization of murine coagulation factor VIII-producing cells in vivo
por: Hayakawa, Morisada, et al.
Publicado: (2021)

Mechano-covalent protection of coagulation factor VIII by von Willebrand factor
por: Butera, Diego, et al.
Publicado: (2022)

Human coagulation factor VIII domain-specific recombinant polypeptide expression
por: Choi, Su Jin, et al.
Publicado: (2015)

Study on Coagulation Factor VIII and Fibrinogen Levels in Patients with Thyroid Disorders
por: Thoyyib, Muhammed, et al.
Publicado: (2018)

Identification of Key Coagulation Activity Determining Elements in Canine Factor VIII
por: Firrman, Jenni, et al.
Publicado: (2020)

Exploring the Complex Role of Coagulation Factor VIII in Chronic Liver Disease
por: Pradhan-Sundd, Tirthadipa, et al.
Publicado: (2021)

Controlling Coagulation in Blood with Red Light
por: Müller, Patricia, et al.
Publicado: (2021)

Convenience Comparison Study of Reconstitution Devices for the Blood Coagulation Factor VIII Products Rurioctocog Alfa Pegol and Antihemophilic Factor (Recombinant)
por: Ueda, Hitoshi, et al.
Publicado: (2020)

Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study
por: Venkateswarlu, Divi
Publicado: (2010)

Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody Inhibitor
por: Ronayne, Estelle K., et al.
Publicado: (2021)

Isolated Variable Domains of an Antibody Can Assemble on Blood Coagulation Factor VIII into a Functional Fv-like Complex
por: Shestopal, Svetlana A., et al.
Publicado: (2022)

Characterization of interaction between blood coagulation factor VIII and LRP1 suggests dynamic binding by alternating complex contacts
por: Chun, Haarin, et al.
Publicado: (2022)

Expression of the gene encoding blood coagulation factor VIII without domain B in E. coli bacterial expression system
por: Mazurkiewicz-Pisarek, Anna, et al.
Publicado: (2023)

Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR/Cas9
por: Park, Chul-Yong, et al.
Publicado: (2019)

Effects of Hemoglobin-Based Oxygen Carriers on Blood Coagulation
por: Roghani, Kimia, et al.
Publicado: (2014)

Detection of Fibrinogen and Coagulation Factor VIII in Plasma by a Quartz Crystal Microbalance Biosensor
por: Yao, Chunyan, et al.
Publicado: (2013)

Mutations in Coagulation Factor VIII Are Associated with More Favorable Outcome in Patients with Cutaneous Melanoma
por: Ping, Zheng, et al.
Publicado: (2017)

Protein residue network analysis reveals fundamental properties of the human coagulation factor VIII
por: Lopes, Tiago J. S., et al.
Publicado: (2021)

Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII
por: Peters, Shaun C., et al.
Publicado: (2022)

New role of hypoxia in pathophysiology of multiple myeloma through miR-210
por: Saba, Fakhredin, et al.
Publicado: (2018)

Maturation of coagulation factor IX during Xase formation as deduced using factor VIII‐derived peptides
por: Fang, Han, et al.
Publicado: (2019)

Progress of in vitro factor VIII coagulant activity from 0 to 8 hours after reconstitution
por: Shim, Ye Jee, et al.
Publicado: (2014)

Long-Term Safety of PEGylated Coagulation Factor VIII in the Immune-Deficient Rowett Nude Rat
por: Rasmussen, Caroline E., et al.
Publicado: (2017)

Six cases of autoimmune acquired coagulation factor VIII deficiency: Single center experience in Japan
por: Konishi, Akiko, et al.
Publicado: (2020)

Therapeutic Effects of Kefir Peptides on Hemophilia-Induced Osteoporosis in Mice With Deficient Coagulation Factor VIII
por: Yen, Chih-Ching, et al.
Publicado: (2022)

The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics
por: Casademunt, Elisabeth, et al.
Publicado: (2012)

Von Willebrand factor and coagulation factor VIII in Moyamoya disease associated with Graves' disease: A case report
por: Ren, Shou-Chen, et al.
Publicado: (2016)

Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels
por: Kiouptsi, Klytaimnistra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ce5irrmeeff4clkv95ku83b5ar